Visinin-like protein 1 (VLP-1) antibody and antigen (Recombinant protein)
Diagnostic Visinin-like protein 1 (VLP-1) antibodies (anti-Visinin-like protein 1, anti-VLP-1) and antigens (recombinant Visinin-like protein 1 (VLP-1) protein) for Neurodegenerative diseases VLP-1 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection
>>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-VLP-1-Ag01 | Recombinant human VSNL1/VLP-1/VISL1 Protein | 3090 |
GMP-h-VLP-1-Ab01 | Anti-human VSNL1/VLP-1/VISL1 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-VLP-1-Ab02 | Anti-human VSNL1/VLP-1/VISL1 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-VLP-1-Ab03 | Anti-human VSNL1/VLP-1/VISL1 human monoclonal antibody (mAb) | 1953 |
GMP-h-VLP-1-Ab04 | Anti-human VSNL1/VLP-1/VISL1 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-VLP-1-Ag01 |
Product Name | Recombinant human VSNL1/VLP-1/VISL1 Protein |
Target/Biomarker | Visinin-like protein 1 (VLP-1) |
Alias of Target/Biomarker | HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1 |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | Visinin-like protein 1 (VLP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VLP-1 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human VSNL1/VLP-1/VISL1 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-VLP-1-Ab01, GMP-h-VLP-1-Ab02 |
Product Name | Anti-human VSNL1/VLP-1/VISL1 mouse monoclonal antibody (mAb) |
Target/Biomarker | Visinin-like protein 1 (VLP-1) |
Alias of Target/Biomarker | HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1 |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Visinin-like protein 1 (VLP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VLP-1 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human VSNL1/VLP-1/VISL1 mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-VLP-1-Ab03, GMP-h-VLP-1-Ab04 |
Product Name | Anti-human VSNL1/VLP-1/VISL1 human monoclonal antibody (mAb) |
Target/Biomarker | Visinin-like protein 1 (VLP-1) |
Alias of Target/Biomarker | HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1 |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Visinin-like protein 1 (VLP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VLP-1 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human VSNL1/VLP-1/VISL1 human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Visinin-like protein 1 (VLP-1, also known as VILIP-1) is a calcium-signaling molecule expressed in neurons. Meta-analysis of seven studies showed that VLP-1 in the cerebrospinal fluid is significantly higher in people with Alzheimer’s disease than in control subjects (effect size = 1.546, p <0.0001).
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments